Rossari Biotech Ltd releases Consolidated Financial Results for December 31, 2022.
Financial Results (Q3 FY2023) – Quarter-over-Quarter Comparison:
Total income of Rossari Biotech Ltd is Rs.390.383 Crores (December 31, 2022) vs. Rs.426.256 Crores (September 30, 2022)
Net profit/loss: Rs.25.681 Crores (December 31, 2022) vs. Rs.23.916 Crores (September 30, 2022)
EPS: Rs.4.63 (December 31, 2022) vs. Rs.4.32 (September 30, 2022)
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹390.383 Cr | ₹426.256 Cr | ⬇ -8.42% |
| Net Profit | ₹25.681 Cr | ₹23.916 Cr | ⬆ 7.38% |
| EPS | ₹4.63 | ₹4.32 | ⬆ 7.18% |
Financial Results (Q3 FY2023) – Year-over-Year Comparison:
Total income of Rossari Biotech Ltd is Rs.390.383 Crores (December 31, 2022) vs. Rs.433.771 Crores (December 31, 2022)
Net profit/loss: Rs.25.681 Crores (December 31, 2022) vs. Rs.22.539 Crores (December 31, 2022)
EPS: Rs.4.63 (December 31, 2022) vs. Rs.4.07 (December 31, 2022)
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹390.383 Cr | ₹433.771 Cr | ⬇ -10.00% |
| Net Profit | ₹25.681 Cr | ₹22.539 Cr | ⬆ 13.94% |
| EPS | ₹4.63 | ₹4.07 | ⬆ 13.76% |
Financial Results (9 Months Ended FY2023) – Year-over-Year Comparison:
Total income of Rossari Biotech Ltd is Rs.1252.093 Crores (December 31, 2022) vs. Rs.1054.066 Crores (December 31, 2021)
Net profit/loss: Rs.78.278 Crores (December 31, 2022) vs. Rs.73.290 Crores (December 31, 2021)
EPS: Rs.14.14 (December 31, 2022) vs. Rs.13.29 (December 31, 2021)
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹1252.093 Cr | ₹1054.066 Cr | ⬆ 18.79% |
| Net Profit | ₹78.278 Cr | ₹73.290 Cr | ⬆ 6.81% |
| EPS | ₹14.14 | ₹13.29 | ⬆ 6.40% |
For More Latest News Click Here
